Book a Meeting

Highly Galactosylated Anti-CD40 (Dacetuzumab) Antibody (CAT#: BioBet-GA-146ZP) Datasheet

Target
CD40
Isotype
IgG1
Description
The Highly Galactosylated Anti-CD40 (Dacetuzumab), a biobetter antibody contains with a high level of galactosylation.
Indication
Lymphoma, B cell
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD40 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
CD40
Full Name
CD40 Molecule
Background
CD40 (CD40 Molecule) is a Protein Coding gene.
Diseases associated with CD40 include Immunodeficiency With Hyper-Igm, Type 3 and Cd40 Ligand Deficiency.
Among its related pathways are NLR Proteins and Cytokine Signaling in Immune system.
Gene Ontology (GO) annotations related to this gene include enzyme binding and receptor activity.
An important paralog of this gene is TNFRSF11A.
Alternative Names
Tumor necrosis factor receptor superfamily member 5; TNFRSF5; p50
Gene ID
958
UniProt ID
P25942
Cellular Localization
Plasma membrane, Extracellular region or secreted
Genecards
11919
Involvement in Disease
Its related pathways are Transcriptional misregulation in cancer and NF-KappaB Family Pathway.
Related Pathways
TNFSF5/CD40LG receptor (PubMed: 31331973). ERK is activated by TRAF6- and map3k8-mediated signals in macrophages and B cells, leading to the induction of immunoglobulin secretion (by similarity).
Function
Cell Biology and Cellular Response antibody; Developmental Biology antibody; Immune System antibody; Pro-B Cell Marker antibody; Pre-B Cell Marker antibody
Field of research
1.Glycosylation at Asn153 and Asn180 2.Glycosylation at Asn153 and Asn180 3.Glycosylation at Asn153 and Asn180
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1
Antibody Clone
Dacetuzumab
Host
Humanized
Species Reactivity
Human
Description
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD40. Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.
Indication
Lymphoma, B cell

Lymphoma, B cell

Related Products

Non-Fucosylated Anti-Human CD40 (SEA-CD40 (Derived from S2C6)) Therapeutic Antibody (CAT#: BioBet-1665ZP)
Non-fucosylated Anti-Human CD40 (Teneliximab) Therapeutic Antibody (CAT#: BioBet-147ZP)
BetterBet™ Anti-CD40 FcγRIIB Binding Enhanced Antibody (CAT#: AES-0622-ZP375)
Non-fucosylated Anti-Human CD40 (Dacetuzumab) Therapeutic Antibody (CAT#: BioBet-146ZP)
Non-fucosylated Anti-Human CD40 (Selicrelumab) Therapeutic Antibody (CAT#: BioBet-148ZP)
Highly Galactosylated Anti-CD40 (Teneliximab) Antibody (CAT#: BioBet-GA-147ZP)
BetterBet™ Anti-CD40 Half-Life Extended Antibody (CAT#: AES-0622-ZP1031)
Highly Galactosylated Anti-CD40 (Selicrelumab) Antibody (CAT#: BioBet-GA-148ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany